Human T-Cell Lymphotropic Virus Type I-Infected Cells Extravasate through the Endothelial Barrier by a Local Angiogenesis-Like Mechanism

Cancer Research

Volumn 64, Issue 6, 2004, Pages 2039-2046

  Bazarbachi, Ali ^a   Merhi, Raghida Abou ^a   Gessain, Antoine ^b   Talhouk, Rabih ^a   El Khoury, Hilda ^a   Nasr, Rihab ^a   Gout, Olivier ^c   Sulahian, Rita ^a   Homaidan, Fadia ^a   De Thé, Hugues ^d   Hermine, Olivier ^e   El Sabhan, Marwan E ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b INSTITUT PASTEUR   (France)

^c Fondation Rotschild   (France)

^d CNRS   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CONNEXIN 43; GELATINASE A; GELATINASE B; TAX PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CANCER INVASION; CELL COMMUNICATION; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRAVASATION; GAP JUNCTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; METASTASIS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROMOTER REGION; SPINAL CORD DISEASE; T CELL LEUKEMIA; T CELL LYMPHOMA; TRANSACTIVATION; TUMOR CELL; VIRUS INFECTIVITY; VIRUS PATHOGENESIS;

CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL COMMUNICATION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CONNEXIN 43; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; GENES, PX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LYMPHOMA, T-CELL; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 12144290035     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2390     Document Type: Article

References (39)

1. Alby L, Auerbach R. Differential adhesion of tumor cells to capillary endothelial cells in vitro. Proc Natl Acad Sci USA 1984;81:5739-43.
2. Nicolson GL. Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta 1988;984:175-224.
3. Pauli BU, Lee CL. Organ preference of metastasis: the role of organ-specifically modulated endothelial cells. Lab Investig 1988;58:379-87.
4. Iozzo RV. Neoplastic modulation of extracellular matrix: colon carcinoma cells release polypeptides that alter proteoglycan metabolism in colon fibroblasts. J Biol Chem 1995;260:7464-73.
5. Liotta LA, Thorgeirsson UP, Garbisa S. Role of collagenase in tumor cell invasion. Cancer Metastasis Rev 1982;1:277-88.
6. Nakajima M, Irimura T, Di Ferrante D, Di Ferrante N, Nicolson GL. Heparan sulphate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science (Wash. DC) 1983;220:611-3.
7. Weiss L. Metastatic inefficiency: intravascular and intraperitoneal implantation of cancer cells. Cancer Treat Res 1996;82:1-11.
8. Auerbach R, Lu WC, Pardon E, Gumkowski F, Kaminska G, Kaminski M. Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correlate of preferential metastasis in vivo. Cancer Res 1987;47:1492-6.
9. Belloni PN, Tressler RJ. Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells. Cancer Metastasis Rev 1990;8:353-89.
10. Pauli BU, Augustin-Voss HG, El-Sabban ME, Johnson RC, Hammer DA. Organ preference of metastasis: role of endothelial cell adhesion molecules. Cancer Metastasis Rev 1990;9:175-89.
11. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-6.
12. Gimbrone M, Leapman S, Cotran R, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 1972;136:261-76.
13. Zetter BR. Angiogenesis and tumor metastasis. Annu Rev Med 1998;49:407-24.
14. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29:15-8.
15. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994;87:503-8.
16. Schneider P, Jerome MV, Paysant J, Soria PC, Vannier JP. The role of angiogenesis in leukemia proliferation. Am J Pathol 1999;155:1007-8.
17. Bellamy WT, Richter L, Frutiger Y, Grogan TM. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 1999;59:728-33.
18. Friesel RE, Maciag T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 1995;9:919-25.
19. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9-22.
20. Cavallaro U, Christofori G. Molecular mechanisms of tumor angiogenesis and tumor progression. J Neurooncol 2000;50:63-70.
21. Hinuma Y, Komoda H, Chosa T, et al. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer 1982;29:631-5.
22. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2:407-10.
23. Bazarbachi A, Hermine O. Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives. Virus Res 2001;78:79-92.
24. Gessain A, Gout O. Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1992;117:933-46.
25. El-Sabban ME, Merhi RA, Haidar HA, et al. Human T-cell lymphotropic virus type I transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells. Blood 2002;99:3383-9.
26. Yeager M, Unger VM, Falk MM. Synthesis, assembly and structure of gap junction intercellular channels. Curr Opin Struct Biol 1998;8:517-24.
27. Paul DL. New functions for gap junctions. Curr Opin Cell Biol 1995;7:665-72.
28. Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996;84:381-8.
29. Spray DC. Molecular physiology of gap junction channels. Clin Exp Pharmacol Physiol 1996;23:1038-40.
30. Deryugina EI, Ratnikov B, Monosov E, et al. MT-1-MMP initiates activation of pro-MMP-2 and integrin αvβ3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res 2001;263:209-23.
31. Hayashibara T, Yamada Y, Miyanishi T, et al. Vascular endothelial growth factor and cellular chemotaxis: a possible autocrine pathway in adult T-cell leukemia cell invasion. Clin Cancer Res 2001;7:2719-26.
32. Hayashibara T, Fujimoto T, Miyanishi T, et al. Vascular endothelial growth factor at high plasma levels is associated with extranodal involvement in adult T cell leukemia patients. Leukemia 1999;13:1634-5.
33. Mori N, Sato H, Hayashibara T, et al. Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness. Blood 2002;99:1341-9.
34. Kegami M, Umehara F, Ikegami N, Maekawa R, Osame M. Selective matrix metalloproteinase inhibitor, N-biphenyl sulfonyl phenylalanine hydroxamic acid, inhibits the migration of CD4+ T lymphocytes in patients with HTLV-I-associated myelopathy. J Neuroimmunol 2002;127:134-8.
35. El-Sabban ME, Pauli BU. Adhesion-mediated gap junctional communication between lung-metastatic cancer cells and endothelium. Invasion Metastasis 1994;14:164-76.
36. Fidler IJ. Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis. Surg Oncol Clin N Am 2001;10:257-69.
37. El-Sabban ME, Pauli BU. Cytoplasmic dye transfer between metastatic tumor cells and vascular endothelium. J Cell Biol 1991;115:1375-82.
38. Eliceiri BP, Puente XS, Hood JD, et al. Src-mediated coupling of focal adhesion kinase to integrin α(v)β5 in vascular endothelial growth factor signaling. J Cell Biol 2002;157:149-60.
39. Saaristo A, Karpanen T, Alitalo K. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene 2000;19:6122-9.